Tevogen Inc. (TVGN) ROE
- 2026-06-30: ROE 243.15%.
- 2026-03-31: ROE 216.97%.
- 2025-12-31: ROE 319.08%.
- 2025-09-30: ROE 396.76%.
Complete source-backed roe history.
- Available history
- 2022-06-30 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | 243.15% |
| 2026-03-31 | 216.97% |
| 2025-12-31 | 319.08% |
| 2025-09-30 | 396.76% |
| 2025-06-30 | 328.95% |
| 2025-03-31 | 458.02% |
| 2024-12-31 | 205.68% |
| 2024-09-30 | 127.86% |
| 2024-06-30 | 77.45% |
| 2024-03-31 | 318.07% |
| 2023-12-31 | 64.05% |
| 2023-09-30 | 59.73% |
| 2023-06-30 | 56.06% |
| 2023-03-31 | 40.68% |
| 2022-12-31 | -12.98% |
| 2022-09-30 | -12.24% |
| 2022-06-30 | -1.21% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | 319.08% |
| 2024-12-31 | 205.68% |
| 2023-12-31 | 64.05% |
| 2022-12-31 | -12.98% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |